“robert-langer” Archives

in
Entry Author Date Location
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples 08/19/16 Texas
As Pfizer Buys, Closes Bind Tx, CEO Hirsch Heads to Agios 08/16/16 Boston
With $40M Bid, Pfizer Set to Buy, And Close, Bankrupt Bind Tx 07/27/16 Boston
San Antonio’s StemBioSys Brings Product to South Korea With SeouLin 07/12/16 Texas
Pfizer Might Buy Bind Therapeutics From Bankruptcy for $20M 07/06/16 Boston
In First Distribution Deal, StemBioSys Teams with Funakoshi in Japan 06/01/16 Texas
Agenovir Gets $10.6M To Take on Viral Infections With CRISPR 05/18/16 San Francisco
East Coast Biotech Roundup: NY Bio, Gender Gap, Zafgen, PureTech & More 05/12/16 Boston
PureTech’s Alivio Debuts With Drug-Delivery Gel for Inflammation 05/10/16 Boston
Pressured by a Lender, Bind Files for Bankruptcy 05/02/16 Boston
Bind Therapeutics Sheds Employees, Considers New Capital or Deals 04/06/16 Boston
InCube Labs Startup Fe3 Plans Iron-Delivering Patch For Anemia 03/04/16 Texas
Pushing Past Preclinical, Arsenal and 480 Biomedical Land $26.5M 06/03/15 Boston
StemBioSys Takes $8M to Build Homes For Stem Cells 04/15/15 Texas
Kyoto Prize Winner Robert Langer on Innovations to Come 03/19/15 Boston
East Coast Biotech Roundup: Emulate, Accelerator, Retrophin, & More 08/01/14 Boston
Langer, Led Zeppelin, and Hookups: Three Days Behind the BIO Scenes 06/27/14 San Diego
East Coast Life Sciences Roundup: NY Genome Center, Acceleron, Bind, & More 09/20/13 Boston
Langer’s Bind Therapeutics Prices IPO at $15 Per Share 09/20/13 Boston
East Coast Life Sciences Roundup: Epizyme, Rodin, Ophthotech, & More 08/16/13 Boston
Buoyed by Partnerships, Bind Therapeutics Floats $80.5M IPO Plan 08/12/13 Boston
Edge Therapeutics Raises $18M to Better Treat Head Injuries 06/04/13 New York
Top 20 Under-the-Radar Trends in Innovation 05/30/13 National
With $30M in Financing, Living Proof Primps for More Good Hair Days 02/21/13 Boston
BIND CEO Says Amgen Deal Marks Nanomedicine Turning Point 01/09/13 Boston
Amgen in $180.5 Million Drug Development Deal with BIND Biosciences 01/08/13 Boston
Blend Therapeutics Raises $16 Million to Fund Cancer Drug Development 12/18/12 Boston
Selecta in Development Deal with Sanofi Worth up to $900 Million 11/28/12 Boston
Pulmatrix Names Clarke CEO, Releases Promising Data on Lung Drug 09/04/12 Boston
Tesaro, Vertex, Infraredx, & More Boston Life Sciences Headlines 06/29/12 Boston
Page 1 of 3 next page »